An International Pulmonary Embolism Registry Using EKOS (KNOCOUT PE)
Retrospective and Prospective International EkoSonic® Registry of the Treatment and Clinical OUTcomes of Patients With Pulmonary Embolism
Sponsor: BTG International Inc.
A observational or N/A phase clinical study on Pulmonary Embolism and Thrombosis, this trial is completed. The trial is conducted by BTG International Inc. and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2023 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Mar 2023 [monthly]
Completed
▶ Show 7 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Jul 2020 [monthly]
Recruiting
-
Nov 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — Nov 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- BTG International Inc.
- Boston Scientific Corporation
For direct contact, visit the study record on ClinicalTrials.gov .